Pay in 4 interest-free payments of $5.99 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Clinical Contraindications Not appropriate for patients with a personal or family history of medullary thyroid carcinoma or MEN 2, or for patients who are pregnant or breastfeeding
Save Zevay's support contact ([email protected]) and legal contact ([email protected]) before you need them
Stable metabolic trajectory from 1 month to 3 months to 6 months: Mean body weight and HbA1c curves showed a stable and durable trajectory over time, consistent with prior Revita clinical study and real-world experience
The individual provider who approved our intake, however, was only identified by name in the patient portal, with no license listed, so independent verification from the patient side is difficult
Importantly, the exenatide-treated subjects demonstrated improvements in their Parkinsons movement symptoms (as measured by the Movement Disorders Society Unified Parkinsons Disease Rating Scale (or MDS-UPDRS)), while the control patients continued to decline
This makes it uniquely suited for oral bioavailability research
US$ 26.92
US$ 22.56
US$ 27.27
